Tianyu Co., Ltd. announced on July 23 that its wholly-owned subsidiary Nuode Pharmaceutical recently received a “Drug Registration Certificate” for brapiprazole tablets approved and issued by the State Drug Administration. This product is used to treat schizophrenia in adults.

Tianyu Co., Ltd. announced on July 23 that its wholly-owned subsidiary Nuode Pharmaceutical recently received a “Drug Registration Certificate” for brapiprazole tablets approved and issued by the State Drug Administration. This product is used to treat schizophrenia in adults.